Derivative exercise or conversion — not an open-market buy.
Traded Oct 28, 2025 · Filed Oct 30, 2025
Travelers's & President, Personal Ins. sold $496K of Travelers shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$496,379
Shares × reported transaction price
12 days after results of Oct 16, 2025, 85 days before results of Jan 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $268.13 on Oct 28, 2025, 15% above its 52-week low and 6% below its high, after a 1% drop over the previous 30 trading days
52-week range $232.43 (Jan 10, 2025) to $284.97 (Oct 7, 2025), 68% of the way up, from 250 adjusted closes. 30 trading days earlier: $271.95 on Sep 16, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.9% | −1.4% | +3.3% |
| 30 days | +7.2% | +0.1% | +7.1% |
| 90 days | +4.1% | +2.3% | +1.8% |
| 180 days | +14.4% | +4.7% | +9.7% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Travelers's Vice Chairman sold $587K of Travelers shares. Nobody planned it ahead of time.
Travelers's Vice Chairman sold $295K of Travelers shares. Nobody planned it ahead of time.